Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales.
Fourth-quarter worldwide sales increased 7% year-over-year to $15.6 billion, with Pharmaceutical and Animal Health revenues growing 7% and 9% respectively.
The company reported a net profit of $3.74 billion or $1.48 per share for the December quarter, compared to a loss of $1.23 billion or $0.48 per share in the prior-year period. On an adjusted basis, earnings climbed to $1.72 per share in Q4 from $0.03 per share in the fourth quarter of 2023.
“Our business remains well-positioned thanks to the dedication of our talented global team, and I am more confident than ever in our long-term growth potential,” said Merck’s CEO Robert Davis.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Earnings Preview: Fastenal Company likely to report higher Q2 sales and profit
Fastenal Company (NASDAQ: FAST), a leading provider of industrial and construction supplies, is set to publish its second-quarter results next week. The company is among the hardest hit by the
What to look for when Netflix (NFLX) reports its Q2 2025 earnings results
Shares of Netflix, Inc. (NASDAQ: NFLX) stayed red on Monday. The stock has gained 50% over the past three months. The streaming giant is scheduled to report its earnings results
Coinbase shines on stablecoin boom, S&P 500 debut. Will the rally continue?
Coinbase Global, Inc. (NASDAQ: COIN) has emerged as the largest and most user-friendly cryptocurrency exchange in the US, since going public a few years ago. It has played a pivotal
